SAN DIEGO, Sept. 4, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at four investor conferences during the first two weeks of September. These four corporate presentations will be webcast.
Friday, September 7th at 8:30 a.m Eastern Time: NewsMakers in the Biotech Industry Conference in New York City
Monday, September 10th at 11:15 a.m. Eastern Time: Rodman & Renshaw Annual Global Investment Conference in New York City
Wednesday, September 12th at 10:55 a.m. Eastern Time: Morgan Stanley Global Healthcare Conference in New York City
Thursday, September 13th at 1:45 p.m. London Time: Bank of America Merrill Lynch Global Healthcare Conference in London
To listen to the live webcast or a replay of the presentations, please visit the Investor Relations section of the Company’s Web site at www.orexigen.com. A replay will be available for 14 days after each event.
Additionally, on Wednesday, September 5th at 4:00 p.m. Eastern Time, Orexigen management will participate in a panel discussion at the Citi 7th Annual Biotech Day event. This event will not be webcast.
About Orexigen Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company’s lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company’s other product candidate, Empatic, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.
Orexigen Contact: | Media Contact: |
McDavid Stilwell | Denise Powell |
VP, Corporate Communications and Business Development | WCG |
(858) 875-8629 | (510) 703-9491 |
SOURCE Orexigen Therapeutics, Inc.
